The insurance trust fund for the Miami police officers’ union has brought a class action suit against AstraZeneca, maker of Nexium, and the manufacturers of generic versions of that drug alleging that the pharmaceutical giant paid the generic companies to keep their drugs off the market.

The plaintiffs allege that the so-called “pay-to-delay” payments resulted in their having to pay higher costs for prescriptions for Nexium.